<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86971</article-id><article-id pub-id-type="doi">10.7554/eLife.86971</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-307083"><name><surname>Tomas Bort</surname><given-names>Elena</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7897-8891</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307084"><name><surname>Joseph</surname><given-names>Megan Daisy</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8313-8467</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307085"><name><surname>Wang</surname><given-names>Qiaoying</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307086"><name><surname>Carter</surname><given-names>Edward Philip</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4499-1101</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307087"><name><surname>Roth</surname><given-names>Nicolas Jaime</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307088"><name><surname>Gibson</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307089"><name><surname>Samadi</surname><given-names>Ariana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307090"><name><surname>Kocher</surname><given-names>Hemant M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307091"><name><surname>Simoncelli</surname><given-names>Sabrina</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7089-7667</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-122325"><name><surname>McCormick</surname><given-names>Peter J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2225-5181</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-209402"><name><surname>Grose</surname><given-names>Richard Philip</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4738-0173</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Centre for Tumour Biology</institution>, <institution>Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">London Centre for Nanotechnology</institution>, <institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Centre for Endocrinology</institution>, <institution>Queen Mary University of London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-20435"><name><surname>White</surname><given-names>Richard M</given-names></name><role>Reviewing editor</role><aff><institution>Memorial Sloan Kettering Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>p.mccormick@qmul.ac.uk</email> (PM);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>r.p.grose@qmul.ac.uk</email> (RG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e86971</elocation-id><history><date date-type="received"><day>14</day><month>02</month><year>2023</year></date><date date-type="accepted"><day>17</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Tomas Bort et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Tomas Bort et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86971-v1.pdf"/><abstract><p>Pancreatic ductal adenocarcinoma (PDAC) continues to show no improvement in survival rates. One aspect of PDAC is elevated ATP levels, pointing to the purinergic axis as<sup> </sup>a potential attractive therapeutic target. Mediated in part by highly druggable extracellular proteins, this axis plays essential roles in fibrosis, inflammation response and immune function. Analysing the main members of the PDAC extracellular purinome using publicly available databases discerned which members may impact patient survival. <italic>P2RY2</italic><sub> </sub>presents as the purinergic gene with the strongest association with hypoxia, the highest cancer cell-specific expression and the strongest impact on overall survival. Invasion assays using a 3D spheroid model revealed P2Y<sub>2</sub> to be critical in facilitating invasion driven by extracellular ATP. Using genetic modification and pharmacological strategies we demonstrate mechanistically that this ATP-driven invasion requires direct protein-protein interactions between P2Y<sub>2 </sub>and αV integrins. DNA-PAINT super-resolution fluorescence microscopy reveals that P2Y<sub>2</sub> regulates the amount and distribution of integrin αV in the plasma membrane. Moreover, receptor-integrin interactions were required for effective downstream signalling, leading to cancer cell invasion. This work elucidates a novel GPCR-integrin interaction in cancer invasion, highlighting its potential for therapeutic targeting.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A27781</award-id><principal-award-recipient><name><surname>Carter</surname><given-names>Edward Philip</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A25137</award-id><principal-award-recipient><name><surname>Carter</surname><given-names>Edward Philip</given-names></name><name><surname>Grose</surname><given-names>Richard Philip</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MRC0227</award-id><principal-award-recipient><name><surname>Tomas Bort</surname><given-names>Elena</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/T008709/1</award-id><principal-award-recipient><name><surname>Joseph</surname><given-names>Megan Daisy</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>DHF\R1\191019</award-id><principal-award-recipient><name><surname>Simoncelli</surname><given-names>Sabrina</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000288</institution-id><institution>Royal Society</institution></institution-wrap></funding-source><award-id>RGS\R2\202038</award-id><principal-award-recipient><name><surname>Simoncelli</surname><given-names>Sabrina</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/N014308/1</award-id><principal-award-recipient><name><surname>Roth</surname><given-names>Nicolas Jaime</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011704</institution-id><institution>Pancreatic Cancer Research Fund</institution></institution-wrap></funding-source><award-id>Tissue Bank Grant</award-id><principal-award-recipient><name><surname>Kocher</surname><given-names>Hemant M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file, or online resources are fully referenced.Human PDAC tumour data were generated by TCGA Research Network (https://www.cancer.gov/tcga) and by the Clinical Proteomic Tumour Analysis Consortium (https://www.proteomics.cancer.gov). The Genotype-Tissue Expression (GTEx) Project was used for the analysis of normal pancreatic tissue samples (https://gtexportal.org).</p></sec><supplementary-material><ext-link xlink:href="elife-86971-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>